OLR1 and psoriasis: Beyond atherosclerosis, LOX-1 promotes inflammation and injury in other conditions, such as systemic lupus erythematosus (41), diabetes mellitus (42), psoriasis (43), rheumatoid arthritis (20), and infection (44).